New treatment options for the management of multiple myeloma

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Multiple myeloma (MM) is a complex disease characterized by considerable genetic heterogeneity. The updated NCCN Guidelines for MM have added new “preferred” regimens for transplant and nontransplant candidates, and have moved some formerly “preferred” regimens to the “other” category. Supportive care has improved outcomes for patients, and new treatments in combination have extended survival for patients with MM. Novel agents on the horizon are poised to raise the bar even further.

Original languageEnglish (US)
Pages (from-to)709-712
Number of pages4
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume15
Issue number5S
DOIs
StatePublished - May 1 2017

    Fingerprint

ASJC Scopus subject areas

  • Oncology

Cite this